Setback for Cladribin in the EU

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
Frank
Family Elder
Posts: 543
Joined: Wed Jan 03, 2007 3:00 pm
Location: Germany

Setback for Cladribin in the EU

Post by Frank »

Regulators mainly took issue with cases of lymphopenia, a lack of a certain type of white blood cells, and with the risk of cancer
http://www.finanznachrichten.de/18052569

--Frank
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
Top
Post Reply

Return to “Drug Pipeline”